Random

psychopharmacology

Image of a brain of an Alzheimer's patient.

·October 14, 2015·2 min read

Alzheimer’s Patients Prescribed Antipsychotics More Frequently Than General Population

A new study reports people with Alzheimer's disease are more likely to use antipsychotic medications, and for longer periods of time, than the general public.

This is a drawing of a depressed woman sitting with her hands around her knees

Featured Neuroscience Open Neuroscience Articles Psychology

·January 3, 2022·4 min read

Researchers Identify Biomarker for Depression and Antidepressant Response

Researchers have identified a novel biomarker for depression and antidepressant response. The biomarker can be identified and monitored through blood samples.

Featured Neuroscience Open Neuroscience Articles Psychology

·January 15, 2018·8 min read

Can Psychedelic Drugs ‘Reconnect’ Depressed Patients with Their Emotions?

Two new studies consider the potential of using psychedelics to help treat depression. Imperial College London researchers report psilocybin, the active compound in magic mushrooms, can help to relieve symptoms of depression without the dulling of emotions associated with SSRIs. The researchers note the psychedelic experience could help to maintain long term mental health for those with treatment resistant depression.

Featured Neuroscience Psychology

·June 14, 2023·6 min read

Probiotics Enhance Antidepressant Efficacy for Major Depressive Disorder

A probiotic blend comprising 14 strains of bacteria can enhance the treatment of major depressive disorder when used alongside antidepressants. This pilot study highlights the potential of probiotics in promoting improvements in mood over an eight-week period. It is a pioneering exploration into how gut health, improved via probiotics, could pave the way for a novel approach to bolster mood and mental health.

Featured Neuroscience Psychology

·August 29, 2018·7 min read

Ketamine’s Antidepressant Effects Tied to Opioid System in the Brain

Researchers report ketamine's antidepressive effects require activation of opioid receptors in the brain. The study highlights the interaction between depression, pain and opioid addiction.

Featured Neuroscience Psychology

·July 18, 2023·4 min read

Study Challenges Longstanding Beliefs About Action of Antipsychotic Medications

Researchers uncovered a pivotal detail that could revolutionize schizophrenia treatment. Contrary to longstanding belief, antipsychotic drugs that mitigate overactive dopamine, a hallmark of schizophrenia, interact primarily with a different type of neuron than originally assumed.

This shows a brain and a swirly background

Brain Cancer Featured Neuroscience Psychology

·February 2, 2020·5 min read

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

A single dose of the psychedelic psilocybin reduces depression, anxiety, and feelings of hopelessness in cancer patients for 12 months after the drug is administered.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 26, 2020·4 min read

Effects of rapid-acting antidepressant ketamine consolidated in sleep?

Brain connections strengthened with treatment from fast-acting antidepressants, such as ketamine, are consolidated during deep sleep. Researchers propose rapid antidepressant treatments share the ability to regulate both synaptic potentiation and homeostatic mechanisms, which may contribute to how the brain reorganizes its activity to defeat depression.

This shows a blurry outline of a man in blue

Featured Neuroscience Psychology

·April 6, 2021·4 min read

Resurging Psychedelic Therapies for Depression

As interest in using psychedelics to treat a range of mental health disorders grows, researchers consider the impact and therapeutic benefits of using psychedelics to help alleviate symptoms of depression.

Featured Neuroscience Psychology

·May 13, 2022·5 min read

Links Connecting Stress, Depression and Heart Disease Risk Found

Mouse study reveals how depression and chronic stress can have an impact on cholesterol-lowering medications and influence the risk of heart disease.

Featured Neuroscience Open Neuroscience Articles Psychology

·August 15, 2017·4 min read

Weight Gain Receptor Linked to Antipsychotic Drug

A new study implicates serotonin 2c receptors with metabolic side effects caused by a common class of antipsychotic medications.

Featured Neuroscience Open Neuroscience Articles Psychology

·January 6, 2023·7 min read

Blood Pressure Drug Holds Promise for Treating PTSD

Clonidine, an FDA-approved medication commonly prescribed to treat blood-pressure disorders and ADHD, shows promise in mitigating the effects of PTSD.

1 2 3 4 … 32

psychopharmacology

Alzheimer’s Patients Prescribed Antipsychotics More Frequently Than General Population

Researchers Identify Biomarker for Depression and Antidepressant Response

Can Psychedelic Drugs ‘Reconnect’ Depressed Patients with Their Emotions?

Probiotics Enhance Antidepressant Efficacy for Major Depressive Disorder

Ketamine’s Antidepressant Effects Tied to Opioid System in the Brain

Study Challenges Longstanding Beliefs About Action of Antipsychotic Medications

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

Effects of rapid-acting antidepressant ketamine consolidated in sleep?

Resurging Psychedelic Therapies for Depression

Links Connecting Stress, Depression and Heart Disease Risk Found

Weight Gain Receptor Linked to Antipsychotic Drug

Blood Pressure Drug Holds Promise for Treating PTSD

Genes Associated with Earlier and Higher Reproduction Linked to Accelerated Aging

Novel Multiple Sclerosis Treatment Shows Promise

Brain’s Response to Crucial Language Hub Removal: New Insights

Did Fermentation Drive Human Brain Evolution?

Subscribe